工程纳米平台用于动脉样硬化板块的治疗学
Yuying Liu1,2, Zeyu Jiang1,2, Xiao Yang1
1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, China.
Advanced healthcare materials
|April 2, 2024
概括
纳米平台为动脉样硬化斑块的早期检测和治疗提供了先进的工具,改善了心血管疾病的结果. 这篇评论强调了纳米医学.
科学领域:
- 心血管医学 心血管医学
- 纳米技术 纳米技术
- 分子成像学分子成像学
背景情况:
- 动脉样硬化斑块形成驱动心血管疾病,早期阶段往往无症状.
- 及时检测和干预对于管理斑块进展和预防严重事件至关重要.
- 目前的诊断和治疗方法在早期斑块识别方面存在局限性.
研究的目的:
- 审查基于纳米平台的早期动脉样硬化检测的非侵入性成像模式.
- 探索纳米医学策略,以提高动脉样硬化斑块治疗的疗效.
- 讨论纳米平台在斑块管理中的临床转化方面的挑战和前景.
主要方法:
- 在动脉样硬化中纳米平台应用的综合文献综述.
- 分析使用纳米平台的非侵入性成像技术.
- 评估使用纳米医学治疗斑块治疗的治疗策略.
主要成果:
- 纳米平台提供高的信号噪声比率,生物可用性和向性用于斑块成像和治疗.
- 通过利用纳米平台的各种非侵入性成像方式,可以实现早期斑块识别.
- 纳米医学策略在提高动脉样硬化斑块治疗的疗效方面表现有前途.
结论:
- 纳米平台对于促进动脉样硬化斑块的早期检测和干预至关重要.
- 需要进一步的研究和临床转化,才能充分实现纳米医学在心血管疾病中的潜力.
- 本综述提供了对动脉样硬化斑块的纳米诊断和纳米治疗的全面视角.
相关概念视频
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...